"The idea that emerging markets are 'too hard' or 'too slow' is outdated

"The idea that emerging markets are 'too hard' or 'too slow' is outdated — the opportunity is huge."

Our Business Development Manager Kayla van den Bergh challenges assumptions about clinical trials in Africa and emerging markets. From Olympic swimming to pharmaceutical logistics, her journey offers fresh insights on what it really takes to succeed where others see only complexity.

Key insights from our conversation:
✔️ Why Africa's clinical trial capability is underestimated
✔️ How athletic discipline translates to supply chain excellence
✔️ What "urgent" really means in clinical logistics
✔️ Why emerging markets are evolving faster than pharma executives think

Read the full interview to discover how COREX approaches emerging markets differently

Back to the list